Table of contents

Electronic pages

• Correspondence on ‘Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor’ by Ishikawa et al

  (31 December, 2019) Free

  Cristina Regueiro, Antonio Gonzalez
• Response to: ‘Corresponence on ‘Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor’ by Ishikawa et al’ by Regueiro and Gonzalez

  (14 February, 2020) Free

  Yuki Ishikawa, Katsunori Ikari, Chikashi Terao
• Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study (10 January, 2020) Free

  Young Ho Lee
• Response to: ‘Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study’ by Lee (10 January, 2020) Free

  Jun Inamo
• Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells (20 December, 2019) Free

  Smriti K Raychaudhuri, Christine Abria, Siba P Raychaudhuri
• Response to: ‘Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells’ by Raychaudhuri et al

  (8 January, 2020) Free

  Mary Canavan, Sarah M Wade, Douglas J Veale, Ursula Fearon
• Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years (13 December, 2019) Free

  Konstantinos Parperis
• Response to: ‘Frequency of MRI changes suggestive of axial spondyloarthritis in the axial in a large population-based cohort of individuals aged <45 years’ by Parperis (3 January, 2020) Free

  Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun
• Correspondence on: ‘Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Wallman et al

  (9 December, 2019) Free

  Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Britta Siegmund, Denis Poddubnyy
• Response to: ‘Correspondence on: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Proft et al.

  (31 December, 2019) Free

  Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
• Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease (9 December, 2019) Free

  Corrado Campochiaro, Giulio Cavalli, Nicola Farina, Alessandro Tomelleri, Giacomo De Luca, Lorenzo Dagna
• Response to: ‘Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease’ by Campochiaro et al

  (20 January, 2020) Free

  Fleur Cohen-Aubart, Neila Benameur, Zahir Amoura, Julien Haroche
• Correspondence on 'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation’ by Braaten et al

  (6 January, 2020) Free

  Fulvia Ceccarelli, Andrea Botticelli, Alain Jonathan Gelibter, Ilaria Leccese, Ramona Lucchetti, Enrico Cortesi, Guido Valesini, Paolo Marchetti, Fabrizio Conti
• Response to: Correspondence on “Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation” by Braaten et al

  (20 January, 2020) Free

  Laura C Cappelli, Clifton O Bingham, Tawnie Braaten, Ami A Shah
• Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers? (31 December, 2019) Free

  Antoine Fayand, Veronique Hentgen, Stephanie Ducharme-Bénard, Pierre Quartier, Brigitte Bader-Meunier, Isabelle Koné-Paut, Gilles Grateau, Sophie Georgin-Lavialle
• Response to: ‘Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers?’ by Fayand et al

  (7 February, 2020) Free

  Marco Gattorno, Michael Hofer, Federica Vanoni, Silvia Federici, Luca Cantarini, Nicolino Ruperto
• Correction: Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis

  (4 January, 2022)